Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen Could Get a Piece of the Obesity Market
06:00am, Wednesday, 27'th Sep 2023
Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ever seen.
Stock Market Correction Picks Up Steam; Stocks To Watch Include Amgen, Arch Resources
05:36pm, Tuesday, 26'th Sep 2023
Sellers hit the stock market again Tuesday. The Nasdaq composite closed just above 13,000 level, but losers swamped winners on the NYSE.
Which Is A Better Pick – PepsiCo Stock Or Amgen?
06:00am, Tuesday, 26'th Sep 2023
We believe that PepsiCo stock (NYSE: PEP) is a better pick over Amgen stock (NASDAQ: AMGN).
Dow Jones Biotech Giant Amgen, Meta Stock, Eye Buy Points In Stock Market Correction
01:02pm, Monday, 25'th Sep 2023
Dow Jones biotech leader Amgen and Meta stock are among the best stocks to watch in today's stock market action.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:31am, Monday, 25'th Sep 2023
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 Dividend Growth Stocks to Buy Right Now
09:37am, Thursday, 21'st Sep 2023
Amgen's prospects remain solid despite recent struggles. Pfizer is poised to show that it isn't just a pandemic stock.
Flee to Healthcare Stocks if Recession Rears its Head?
07:04am, Wednesday, 20'th Sep 2023
If you're looking for a sector that's on sale, look to healthcare. The Health Care Select Sector SPDR Fund NYSEARCA: XLV is down 2.50% in the past month, lagging the S&P 500.
Nvidia and Amgen back AI drug developer Generate:Biomedicines' $273M financing
11:29am, Thursday, 14'th Sep 2023
Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical and clinical development across oncology, immunology, and infectious disease, including filing mu
Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines' $273 mln fundraise
08:41am, Thursday, 14'th Sep 2023
Drug developer Generate:Biomedicines, which uses artificial intelligence (AI) to find new treatments, said on Thursday it has raised $273 million from investors including Nvidia's venture capital arm
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
The 3 Most Undervalued Biotech Stocks to Buy in September 2023
09:22pm, Tuesday, 12'th Sep 2023
It's been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors.
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
10:36am, Tuesday, 12'th Sep 2023
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Which Is A Better Pick – Honeywell Stock Or Amgen?
09:00am, Monday, 11'th Sep 2023
We believe that Honeywell stock (NYSE: HON) and Amgen stock (NASDAQ: AMGN) will offer little returns in the next three years.
Amgen: Not An Investment Mistake, But It Was Better Before
11:35am, Thursday, 07'th Sep 2023
Amgen could report great quarterly results with revenue, operating income and EPS growing with a solid pace. The stock is undervalued in my opinion and Amgen could be seen as a good investment. Howeve
Call of the day: The health care trade
01:30pm, Wednesday, 06'th Sep 2023
CNBC's Halftime traders Steve Weiss, Liz Young, Joe Terranova, and Brian Belski discuss the call of the day: health care.
